Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia.

Brown FC, Still E, Koche RP, Yim CY, Takao S, Cifani P, Reed C, Gunasekera S, Ficarro SB, Romanienko P, Mark W, McCarthy C, de Stanchina E, Gonen M, Seshan V, Bhola P, O'Donnell C, Spitzer B, Stutzke C, Lavallée VP, Hébert J, Krivstov AV, Melnick A, Paietta EM, Tallman MS, Letai A, Sauvageau G, Pouliot G, Levine R, Marto JA, Armstrong SA, Kentsis A.

Cancer Discov. 2018 Feb 5. pii: CD-17-1271. doi: 10.1158/2159-8290.CD-17-1271. [Epub ahead of print]

PMID:
29431698
2.
3.

ProteoModlR for functional proteomic analysis.

Cifani P, Shakiba M, Chhangawala S, Kentsis A.

BMC Bioinformatics. 2017 Mar 4;18(1):153. doi: 10.1186/s12859-017-1563-6.

4.

Towards comprehensive and quantitative proteomics for diagnosis and therapy of human disease.

Cifani P, Kentsis A.

Proteomics. 2017 Jan;17(1-2). doi: 10.1002/pmic.201600079. Epub 2016 Dec 21. Review.

5.

Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia.

Brown FC, Cifani P, Drill E, He J, Still E, Zhong S, Balasubramanian S, Pavlick D, Yilmazel B, Knapp KM, Alonzo TA, Meshinchi S, Stone RM, Kornblau SM, Marcucci G, Gamis AS, Byrd JC, Gonen M, Levine RL, Kentsis A.

Br J Haematol. 2017 Jan;176(1):86-91. doi: 10.1111/bjh.14413. Epub 2016 Oct 21.

6.

Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.

Waldemarson S, Kurbasic E, Krogh M, Cifani P, Berggård T, Borg Å, James P.

Breast Cancer Res. 2016 Jun 29;18(1):69. doi: 10.1186/s13058-016-0732-2.

7.

A High-Efficiency Cellular Extraction System for Biological Proteomics.

Dhabaria A, Cifani P, Reed C, Steen H, Kentsis A.

J Proteome Res. 2015 Aug 7;14(8):3403-8. doi: 10.1021/acs.jproteome.5b00547. Epub 2015 Jul 14.

8.

Molecular Portrait of Breast-Cancer-Derived Cell Lines Reveals Poor Similarity with Tumors.

Cifani P, Kirik U, Waldemarson S, James P.

J Proteome Res. 2015 Jul 2;14(7):2819-27. doi: 10.1021/acs.jproteome.5b00375. Epub 2015 Jun 22.

PMID:
26055192
9.

Quantitative analysis of a phosphoproteome readily altered by the protein kinase CK2 inhibitor quinalizarin in HEK-293T cells.

Franchin C, Cesaro L, Salvi M, Millioni R, Iori E, Cifani P, James P, Arrigoni G, Pinna L.

Biochim Biophys Acta. 2015 Jun;1854(6):609-23. doi: 10.1016/j.bbapap.2014.09.017. Epub 2014 Sep 30.

PMID:
25278378
10.

Multimodel pathway enrichment methods for functional evaluation of expression regulation.

Kirik U, Cifani P, Albrekt AS, Lindstedt M, Heyden A, Levander F.

J Proteome Res. 2012 May 4;11(5):2955-67. doi: 10.1021/pr300038b. Epub 2012 Apr 21.

PMID:
22471554
11.

Critical comparison of multidimensional separation methods for increasing protein expression coverage.

Antberg L, Cifani P, Sandin M, Levander F, James P.

J Proteome Res. 2012 May 4;11(5):2644-52. doi: 10.1021/pr201257y. Epub 2012 Apr 6.

PMID:
22449141
12.

Relative quantification of membrane proteins in wild-type and prion protein (PrP)-knockout cerebellar granule neurons.

Stella R, Cifani P, Peggion C, Hansson K, Lazzari C, Bendz M, Levander F, Sorgato MC, Bertoli A, James P.

J Proteome Res. 2012 Feb 3;11(2):523-36. doi: 10.1021/pr200759m. Epub 2011 Nov 18.

PMID:
22023170
13.

Hunting for protein markers of hypoxia by combining plasma membrane enrichment with a new approach to membrane protein analysis.

Cifani P, Bendz M, Wårell K, Hansson K, Levander F, Sandin M, Krogh M, Ovenberger M, Fredlund E, Vaapil M, Pietras A, Påhlman S, James P.

J Proteome Res. 2011 Apr 1;10(4):1645-56. doi: 10.1021/pr100982j. Epub 2011 Feb 23.

PMID:
21235201

Supplemental Content

Loading ...
Support Center